Market News
Stay updated with the latest market trends, earnings, and economic indicators.
Stocks in news: TCS, Groww, Shriram Finance, Dixon Tech, Anand Rathi Wealth
Indian markets saw a rebound on Thursday, recovering from Wednesday's sharp sell-off. TCS reported a 5% year-on-year profit growth, and Groww affirmed its direct mutual fund strategy. Shriram Finance is raising funds to reduce borrowing costs after a rating upgrade. Maruti Suzuki plans to add service points, and Dixon Tech will expand smartphone manufacturing. Premier Energies commissioned a solar module facility, and Anand Rathi Wealth saw profit rise.
Vatika Hotels refinance Rs 550 crore debt with Kotak
Vatika Hotels has refinanced Rs 550 crore debt with Kotak Mahindra Bank. This move marks the exit of India Special Assets Fund III from the company. The hotel owner experienced financial stress during the Covid-19 pandemic. Vatika Hotels' debt has significantly declined after restructuring and equity infusion. The company now holds a BBB investment-grade rating, reflecting improved financial health.
Why top fund managers think foreign investors could return to India
India's market outlook is improving as oil prices ease and geopolitical risks recede. Sunil Singhania, Founder of Abakkus Asset Manager, Prashant Khemka, Founder, Whiteoak Capital and Nilesh Shah, Managing Director at Kotak Mahindra AMC explain why foreign investor sentiment could improve, where earnings growth is strongest, and which sectors—from banks to renewables—offer the most compelling opportunities.
PE investor BC Investments sells Rs 612 crore stake in Emcure Pharma; Kotak MF picks up stake
Private equity firm BC Investments IV sold a Rs 612 crore stake in Emcure Pharmaceuticals to Kotak Mahindra Mutual Fund at Rs 1,700 per share. Despite this divestment, analysts remain positive on Emcure's growth outlook across its core therapeutic segments.
Ajanta Pharma promoter sells ₹1,024 crore stake; mutual funds step in as buyers
A promoter entity of Ajanta Pharma has sold a 2.8% stake in the drugmaker for over ₹1,000 crore through a block deal, with Kotak Mahindra Mutual Fund and Aditya Birla Sun Life Mutual Fund emerging as the key buyers.
Promoter sells Rs 1,024 crore worth of Ajanta Pharma shares in block deal to Kotak MF and ABSL MF
A promoter entity of Ajanta Pharma sold shares worth over Rs 1,024 crore through a block deal, with Kotak Mahindra Mutual Fund and Aditya Birla Sun Life Mutual Fund acquiring the stake. The transaction comes amid strong earnings growth, healthy margins and sustained momentum in the company’s pharmaceutical business.
NLC India shares in focus as government's Offer For Sale opens for non-retail investors
Among the public shareholders, mutual funds of India had a 9.49% stake in NLC India, led mainly by Nippon Life India AMC (5.65%) and Kotak Mahindra MF (2.6%). The stock is up over 30% so far in 2026.
ED Arrests Ex-Kotak Mahindra Bank VP In Panchkula Municipal Body 'Fraud' Case
ED arrested ex-Kotak Mahindra Bank official Pushpinder Singh, alleging his role in the Panchkula Municipal Corporation fund fraud case.
The Great Consumption Reset: How a billion Indians changed what they buy
India's consumption landscape is evolving, with consumers favouring experiences, digital services, and premium products over basic goods. Kotak Mutual Fund's report shows a surge in foreign travel spending and premium smartphone sales, indicating a shift towards higher-value purchases.
Kotak AMC’s Shibani Sircar Kurian bets on financials and healthcare; cautious on IT
Shibani Sircar Kurian, Head -Equity Research and Fund Manager at Kotak Mahindra AMC, which manages assets worth nearly $4.79 billion, said the ongoing Middle East conflict remains the biggest concern for Indian markets due to its potential impact on oil prices, growth and earnings. She said Kotak AMC remains selective, favouring financials, healthcare and parts of industrials, while staying cautious on smallcaps and Indian IT amid AI-led disruption. Disclaimer: The views and investment tips expressed by investment experts on CNBCTV18.com are their own and not that of the website or its management. CNBCTV18.com advises users to check with certified experts before taking any investment decisions.
Indian fund outperforming 98% of peers bets on defense stocks
A $3 billion fund at Kotak Mahindra Asset Management Co. is backing Indian defense stocks, wagering that geopolitical tensions will boost local arms production and support the government’s efforts to lower reliance on imports.
Mutual fund bulls vs FII bears: The Rs 38,000 crore battle for 5 popular bank stocks
Domestic mutual funds bought banking stocks worth Rs 38,000 crore in March, countering heavy FII selling of Rs 60,655 crore during the Iran war selloff. Major accumulation was seen in HDFC Bank, ICICI Bank, SBI, Kotak Mahindra Bank, and Axis Bank. HDFC Bank emerged as the top pick across leading mutual fund houses, according to Prime Database estimates.